Bio pharmaceutical company Worg Pharma, which focuses on providing breakthrough immunotherapy solutions, announced the completion of a new round of financing worth hundreds of millions of yuan. This round of financing is jointly invested by multiple well-known institutions and industry investors, including PICC Capital Equity, Qingsong Capital, and a well-known industry investment institution...
Recently, Worg Pharma Biotechnology, a biopharmaceutical company specializing in providing breakthrough immunotherapy solutions...
Worg Pharma announced the completion of over 1.1 billion RMB in Series C financing.
The biopharmaceutical company Worg Pharma completes nearly 400 million RMB Series B financing...
Scan
WeChat official account
A wholly-owned subsidiary of Worg PHARMA
